EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes

Andrea Mogavero iD, Paolo Bironzo iD, Luisella Righi iD, Alessandra Merlini, Federica Benso, Silvia Novello, Francesco Passiglia

Life · 31.05.2023 · 13 (6) · 1291

DOI: 10.3390/life13061291 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 31.05.2023. Verfasst von Andrea Mogavero und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Italy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is one of the most frequently diagnosed cancers worldwide and the leading cause of cancer-related death. The 2021 World Health Organization (WHO) classification provided a detailed and updated categorization of lung adenocarcinomas with a special focus on rare histological types, including enteric, fetal and colloid types, as well as not otherwise specified adenocarcinoma, overall accounting for about 5–10% of all cases. However, rare entities are nowadays difficult to diagnose in most centers, and evidence of optimal therapeutic management for these patients is still lacking. In recent years, increasing knowledge about the mutational profile of lung cancer, in addition to the spreading diffusion of next-generation sequencing (NGS) in different centers, have been helpful in the identification of rare variants of lung cancer. Hence, the hope is that several new drugs will be available in the near future to treat these rare lung tumors, such as in targeted therapy and immunotherapy, which are often used in clinical practice for several malignancies. The aim of this review is to summarize the current knowledge about the molecular pathology and clinical management of the most common rare adenocarcinoma subtypes in order to provide a concise and updated report that can drive clinicians’ choices in their routine practice.

Schlagwörter

Stichwörter der Autor:innen

NOS carcinomacolloid carcinomacolorectal cancerfetal carcinomaimmunochemistrymutation analysespulmonary enteric carcinoma

Autor:innen und Institutionen

  • Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Italy.

ORCID-Profile: Andrea Mogavero, Paolo Bironzo, Luisella Righi

Zitieren

APA

Mogavero, A., Bironzo, P., Righi, L., Merlini, A., Benso, F., Novello, S., & Passiglia, F. (2023). Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes. Life, 13(6), 1291. https://doi.org/10.3390/life13061291

Vancouver

Mogavero A, Bironzo P, Righi L, Merlini A, Benso F, Novello S, et al. Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes. Life. 2023;13(6):1291. doi:10.3390/life13061291

BibTeX
@article{Mogavero2023,
  author = {Mogavero, Andrea and Bironzo, Paolo and Righi, Luisella and Merlini, Alessandra and Benso, Federica and Novello, Silvia and Passiglia, Francesco},
  title = {Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes},
  journal = {Life},
  year = {2023},
  volume = {13},
  number = {6},
  pages = {1291},
  doi = {10.3390/life13061291}
}
Kostenlos starten →